The arrival of Retatrutide in the country is generating significant buzz within the medical community. This novel dual medication – acting on both GLP-1 and GIP receptors – presents a potentially significant tool https://health-lists.com/story22894422/australia-s-retatrutide-australia-a-possible-fresh-hope-for-weight-management